Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia - Report - MDSpire

Spatial transcriptomics reveals molecular differences associated with malignant transformation in oral epithelial dysplasia

  • By

  • Naren Raja

  • Harsh B. Pathak

  • Amrita Mitra

  • Sufi Mary Thomas

  • Yong Wang

  • Tanya Marie Gibson

  • Rong Wang

  • July 10, 2026

  • 0 min

Share

Clinical Report: Spatial Transcriptomic Analysis of Oral Epithelial Dysplasia

Overview

This study utilized spatial transcriptomics to analyze benign, oral epithelial dysplasia (OED), and oral squamous cell carcinoma (OSCC) biopsies. It identified 11 differentially expressed genes (DEGs) associated with malignant transformation in OED.

Background

Oral epithelial dysplasia (OED) is a precancerous condition that can progress to oral squamous cell carcinoma (OSCC), which poses a significant health burden globally. Understanding the molecular mechanisms behind this progression is crucial. This study aims to elucidate the molecular variations linked to malignant progression in OED using advanced spatial transcriptomic techniques.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Identified 11 epithelial DEGs in transforming OED compared to non-transforming OED.
  • DEGs included genes related to antigen presentation and interferon signaling (e.g., B2M, STAT1, CD74).
  • No significant DEGs were found in immune-enriched regions of OED.
  • Pathway analyses indicated enrichment of immune- and interferon-related processes in transforming OED.
  • Findings are exploratory and require validation due to the modest sample size.

Clinical Implications

Further validation is necessary for the findings.

Conclusion

This study provides preliminary insights into the molecular differences in OED lesions.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Molecular and microenvironmental drivers of malignant transformation from oral potentially malignant disorders to oral squamous cell carcinoma
  2. conexiant -- Mutational Signatures May Define Oral Cancers
  3. the asco post -- Spatial Transcriptomics Identifies Novel Subtypes Associated With Disease Prognosis in Leiomyosarcoma
  4. Frontiers in Oncology, 2026 -- HOX gene dysregulation in head and neck squamous cell carcinoma: mechanisms, clinical relevance, and future perspectives
  5. Cambridge.org -- Head and neck cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition
  6. AAOMS -- Oral mucosal dysplasia position paper
  7. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 - PubMed
  8. S0022215123001615jed 1..224
  9. https://www.aaoms.org/wp-content/uploads/2024/03/oral_mucosal_dysplasia_position_paper.pdf
  10. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025 - PubMed
  11. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial - PMC
  12. Randomized Controlled Trials for Oral Leukoplakia - Lodolo - 2025 - Oral Diseases - Wiley Online Library
  13. Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia | Division of Cancer Prevention
  14. Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta‐analysis - PMC
  15. Malignant transformation rate of oral precancerous disorders to oral cancer: systematic review and meta-analysis of the current evidence - PMC
  16. DNA ploidy status as a predictor for malignant transformation in oral leukoplakia: a systematic review and meta-analysis - PubMed

Original Source(s)

Related Content